Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical Plc LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.25 1.89% 13.50 13.00 14.00 13.625 13.25 13.25 490,149 10:02:51
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -7.2 -4.5 - 33

Futura Medical Share Discussion Threads

Showing 17026 to 17048 of 18775 messages
Chat Pages: Latest  691  690  689  688  687  686  685  684  683  682  681  680  Older
DateSubjectAuthorDiscuss
16/7/2019
10:27
It's up in 5 -10minutes......but how long does it stay up?Some women can be very demanding
kop202
16/7/2019
10:15
The question must be whether any potential licensee decides it is better to conclude a deal at these levels? If not, pay possibly vast amounts more,in a bidding war with other players. The product is first major ED breakthrough in 20 years. Is applied topically Works within 5 to 10 mins v up to one hour for Viagra,Cialis etc. Please form an orderly queue.
j777j
16/7/2019
09:59
But why wait till Sept/Dec when the writing is on the wall now about the potential
tiananmen
16/7/2019
09:52
Assuming regulatory approval for both MED2005 and TPR100 (the odds of which are getting ever more short) this will be in the pounds not pence, however I cant find an explanation for the last few days rise. MED2005 is well off until end of year (earliest end Oct, probably later) and nothing is expected from Thornton & Ross on TPR100 Until Sept earliest. So there is something else out there – Good obviously...but what?
ragnarr
16/7/2019
09:04
135k gone through. Someone is confident!
ch4p_85
16/7/2019
08:32
From where I am looking Singer N+1 forecast $90 million in upfront and milestone payments for Europe and USA. That is fairly near to the entire market cap alone. They also forecast 15% royalties. The consensus is the med gel can reach $1 billion in annual sales. Does not take much to work out how many royalties will come in at 25% of that ( $37.5 million pa) up to 100%($150 million pa.) Big big numbers. We also know Eli Lilly bought the remaining 50% its Cialis joint venture from Icos for $2.3 billion. That after having paid $75 million upfront after only a patchy phase 2 trial.
j777j
16/7/2019
08:22
UP 768%+ since the beginning of this year - keep chasing ;-)
5oletrader
16/7/2019
08:21
Looks like it doesn’t it! DYOR
qs99
16/7/2019
08:08
something definitely going on ?
ragnarr
16/7/2019
07:54
takeover bid imminent = explosionnnn to £1++ quickly
ih_116147
16/7/2019
07:27
There is no doubt that as we get closer to november,awareness will rise.
j777j
16/7/2019
06:56
will we see some more fireworks today?
qs99
15/7/2019
14:44
well it is being well bought IMO!
qs99
15/7/2019
14:25
For all those getting carried away, Lombard odier haven't gone away.every time price moves up on big volume,they reduce.Cant be long before their next rns.
wantage
15/7/2019
14:17
double wow
qs99
15/7/2019
14:08
wow, there really is some good support here, well done all those that have kept the faith!
qs99
15/7/2019
12:41
Another MONSTER buying opp guys is the Novartis Spin-off Mereo Biopharma (MPH.L) which trading below cash balance the current market cap is only £44 million thats nothing for a company with 3 x Phase 3 ready Programs . Good news out today on that undiscovered stock , check it out guys you will like it . MPH.L trading at 44p Mereo BioPharma---Focus shifts back to imminent data hxxps://www.trinitydelta.org/research-notes/focus-shifts-back-to-imminent-data/ rNPV valuation of 506p/share We re-introduce our estimates and valuation of Mereo following the completion of the OncoMed transaction. We value Mereo using a rNPV methodology of its four leading assets at £541m ($704m), equivalent to 506p/share or $25.59/ADS (fully diluted). As indicated, there are multiple significant catalysts due in 2019, which could lead to major re-ratings of the shares.
ih_116147
15/7/2019
12:16
It is so clear that this company is very undervalued, if you think that they can wipe out the competition Viagra. By the end of the year is certainly to be expected with a BIG Deal or company Takeover! Definitely!
firstman
15/7/2019
12:04
I think some know more and cover up piece by piece.
firstman
15/7/2019
11:58
Bid could be in the £1-1.20 range
ih_116147
15/7/2019
11:57
You will be rewarded with Brucie Bonus
kop202
15/7/2019
11:46
Does Fum manage to remain independent and retain all the rights,or will someone just snap it up? Let's face it there are not that many co's around with a low market cap that might deliver a blockbuster drug ($1 billion sales.) We will find out soon enough.
j777j
15/7/2019
11:42
RALLYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY see you at £1.50++ by year end
ih_116147
Chat Pages: Latest  691  690  689  688  687  686  685  684  683  682  681  680  Older
Your Recent History
LSE
FUM
Futura Med..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200222 23:09:50